Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial by Erlendsson, Andrés Már, MD, PhD, Karmisholt, Katrine Elisabeth, MD, Haak, Christina Skovbølling, MD, PhD, Stender, Ida-Marie, MD, PhD, Haedersdal, Merete, MD, PhD, DMSc

Get full text